Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
des(carbamimidoyl) zanamivir
- Development stage
- Unknown
- Modality
- Small Molecules
01
Overview
Des(carbamimidoyl) zanamivir is a synthetic small molecule and an analog of zanamivir. It is structurally related to the neuraminidase inhibitor class of antivirals but lacks the carbamimidoyl (guanidino) group present in zanamivir. This compound has been studied primarily as a research tool and not as an approved therapeutic agent. Like zanamivir, it acts by inhibiting viral neuraminidase enzymes—key proteins that catalyze the removal of terminal sialic acid residues from viral and cellular glycoconjugates—thereby blocking the release of new influenza virus particles from infected cells[1][7][8]. Des(carbamimidoyl) zanamivir has been used in structural biology studies to understand neuraminidase binding but has not advanced into clinical development or approval for any indication.
- Other names
- 4-amino-2-deoxy-2,3-dehydro-N-acetylneuraminic acid4-amino-Neu5Ac2enZanamivir AmineD-glycero-D-galacto-non-2-enonic acid, 5-(acetylamino)-4-amino-2,6-anhydro-3,4,5-trideoxy-
02
Targets
Neuraminidase
Beyond the preview
Go deeper on des(carbamimidoyl) zanamivir.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on des(carbamimidoyl) zanamivir.